Core Insights - The medical device ETF (159873) has shown significant trading activity with a turnover of 10.71% and a transaction volume of 12.03 million yuan as of January 6, 2026, indicating a vibrant market [1] - The ETF has experienced substantial growth, with an increase of 26.77 million yuan over the past year and a rise of 23 million units in the last three months [1] - Neuralink is set to begin large-scale production of brain-computer interface technology, marking a significant advancement in the industry [1] Product Highlights - The medical device ETF (159873) closely tracks the CSI All-Share Healthcare Equipment and Services Index, which selects listed companies related to healthcare to reflect the overall performance of this sector [1] Industry Trends - The brain-computer interface industry is witnessing a surge in clinical advancements and diverse technological approaches, leading to a competitive landscape [2] - According to Open Source Securities, the brain-computer interface sector is in a high-growth phase driven by technological breakthroughs, policy support, and collaborative robotics ecosystems [2] - The global brain-computer interface market is projected to reach approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034 [2]

Core Insights - The competition for brain-computer interface (BCI) technology is intensifying, with significant implications for human interaction and technology, comparable to the advent of the internet [1] - China is making strategic investments in BCI technology, aiming to establish itself as a leader in this emerging field [5] Technology Overview - BCI technology establishes a direct connection between the brain and external devices, translating neural signals into commands for machines, enabling functionalities like mobility for paralyzed individuals and communication for those unable to speak [2] - There are three main types of BCI technologies: non-invasive, semi-invasive, and invasive, each with varying levels of risk and signal quality [3] Industry Development - By 2025, China aims to achieve significant breakthroughs in BCI technology, with plans to create several industrial clusters and nurture global leaders in the field by 2030 [5] - The inclusion of BCI in China's national economic planning marks a shift from research to a strategic focus on technological advancement [5] Clinical Advancements - Clinical trials for invasive BCI technologies are progressing, with companies like Neuralink and domestic firms achieving significant milestones in patient treatments [6][7] - Non-invasive BCI applications are also expanding in medical and consumer markets, with several companies preparing to launch products [7] Market Growth - The global BCI market is projected to grow from $1.2 billion in 2019 to nearly $2 billion in 2023, with a compound annual growth rate (CAGR) exceeding 13% [9] - China's BCI market is expected to reach approximately $3.2 billion in 2024, with further growth anticipated [10] Investment Landscape - Investment in the BCI sector has seen fluctuations, with a peak in 2021-2022, but is expected to rebound due to supportive policies and government initiatives [11] - Most funding is directed towards invasive BCI solutions, with a significant number of investments occurring in early-stage rounds [11] Key Players - Companies involved in BCI technology span various sectors, including those focused on core components like electrodes and chips, as well as those developing applications in healthcare and consumer products [13][14][15] - Notable companies include Sanbo Brain Science, which has participated in pioneering clinical trials, and Yingqu Technology, a leading player in BCI device sales [17][18]

Market Overview - The Shanghai Composite Index opened high and rose over 1%, breaking the previous high from November 14, 2025, reaching a ten-year peak [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.78 trillion yuan, an increase of 145.5 billion yuan compared to the previous trading day [2] Sector Performance - Multiple sectors showed strong performance, with nearly 3,700 stocks rising across the market [3] - The brain-computer interface concept continued to be strong, with over ten constituent stocks hitting the daily limit, including Sanbo Brain Science and Meihao Medical [3] - The financial sector also performed well, with Huayin Securities hitting the daily limit and both Xinhua Insurance and China Pacific Insurance rising over 6% [3] - The non-ferrous metals sector was active, with companies like Luoyang Molybdenum and Zijin Mining reaching historical highs [3] - The commercial aerospace concept remained active, with Luxin Investment achieving six limit-ups in eight days [3] Decline in Specific Sectors - The computing hardware concept saw a decline, with Hui Lv Ecology experiencing a significant drop [4] Closing Statistics - At the close, the Shanghai Composite Index rose by 1.14%, the Shenzhen Component Index increased by 0.81%, while the ChiNext Index fell by 0.04% [5] - Specific index values were: Shanghai Composite Index at 4069.38, Shenzhen Component Index at 3293.18, and ChiNext Index at 13940.24 [6] Market Sentiment - 84.02% of users are bullish on the market [7] - A total of 3,695 stocks rose, while 1,590 stocks declined, with 107 stocks hitting the daily limit [8] Trading Metrics - The trading volume for the day was 1.78 trillion yuan, with a predicted volume of 2.77 trillion yuan for the next trading day, an increase of 226 billion yuan [10] - The limit-up performance rate was 85%, with a high opening rate of 81% and a profit rate of 85% [10]

扬子晚报网1月6日讯(记者范晓林实习生潘伊笑)1月6日，截至午盘，沪指高开高走涨超1%，截至午盘至4069.38点，突破前期高点4034.08点，刷新10年来 新高。沪深京三市上涨个股超3700只。 | 11:38 | | ·Il 5G C | | | --- | --- | --- | --- | | ◀ 上证指数 ▶ | | | | | 1A0001 | | | | | 4069.38 | | | + | | +45.96 +1.14% | | | 加自选 | | 今开 4026.02 最高 4069.91 | | 成交量 | 4.40亿 | | 昨收 4023.42 最低 4025.09 | | 成交额 | 7423.20亿 | | 量比 1.61 委比 8.86% | | 振 幅 | 1.11% | | ul 直播 春季行情启动! 黑马方向看这些? 机器... × | | | | | 分时 五日 周K | | 月K 更多、 | O | | 领先4060 最新4069.38 +45.96 +1.14% | | | | | A 180 V A | 4069.91 | | 1.16% | | | | | 0 ...

Market Performance - The Shanghai Composite Index rose by 1.14% to 4069.38 points, reaching a new high in over 10 years [1] - The Shenzhen Component Index increased by 0.81% to 13940.24 points, while the ChiNext Index fell by 0.04% to 3293.18 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 178.13 billion yuan, with over 3600 stocks rising [1] Sector Performance - The leading sectors included brain-computer interfaces, chemical engineering, non-ferrous metals, insurance, securities, semiconductors, and photovoltaic equipment [2][3] - The non-ferrous metals sector saw a significant increase of 4.05%, while non-bank financials and oil & petrochemicals rose by 3.27% and 2.95%, respectively [3] - The brain-computer interface sector experienced a surge, with multiple stocks hitting the daily limit [3] Institutional Insights - Huatai Securities anticipates a strengthening spring market, recommending investments in growth sectors such as electric equipment and renewable energy, as well as domestic demand improvement themes [4] - CITIC Securities suggests that the cross-year market will exhibit characteristics of "growth leading and liquor accumulating," with a focus on sectors like snacks and dairy [5] - Guoxin Securities predicts that 2026 will be a significant year for the market, supported by favorable macro policies and improving corporate earnings [6] Emerging Opportunities - Guoxin Securities highlights the potential for 2026 to be the year of reusable commercial rockets, driven by the need for cost-effective launch solutions [7] - Tianfeng Securities expresses optimism about the growth potential in high-end consumer sectors such as cosmetics, gold jewelry, and duty-free shopping [8]

Market Performance - The three major A-share indices showed mixed performance in the morning session, with the Shanghai Composite Index rising by 1.14% to 4069.38 points, reaching a new high since July 2015 [1] - The Shenzhen Component Index increased by 0.81%, while the ChiNext Index fell by 0.04%, and the North Star 50 Index rose by 0.86% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 179.61 billion yuan, an increase of 147.2 billion yuan compared to the previous day, with over 3600 stocks rising [1] Sector Highlights - The brain-computer interface concept saw a resurgence, with nearly 20 stocks, including Sanbo Brain Science and Nanjing Panda Electronics, hitting the daily limit [1] - Insurance stocks continued their upward trend from the previous day, with New China Life Insurance and China Pacific Insurance reaching new highs, while Ping An Insurance hit a new high not seen in over five years [1] - The non-ferrous metals sector performed strongly, with companies like Luoyang Molybdenum, Zijin Mining, and Jiangxi Copper all reaching new highs [1]

Market Performance - The three major indices showed mixed performance in early trading, with the Shanghai Composite Index up by 1.14%, the Shenzhen Component Index up by 0.81%, and the ChiNext Index down by 0.04% [1] - The total trading volume in the Shanghai, Shenzhen, and Beijing markets reached 1.7961 trillion yuan, an increase of 147.2 billion yuan compared to the previous day [1] - Over 3,600 stocks in the market experienced gains [1] Sector Performance - The brain-computer interface, chemical, non-ferrous metals, insurance, securities, semiconductor, and photovoltaic equipment sectors saw significant gains [1] - The brain-computer interface sector experienced a resurgence, with nearly 20 stocks, including Sanbo Brain Science and Weisi Medical, hitting the daily limit [1] - The insurance sector continued its strong performance, with Xinhua Insurance and China Pacific Insurance reaching new highs [1] - The non-ferrous metals sector also performed well, with Zijin Mining's total market capitalization surpassing 100 billion yuan, setting a historical high [1] - The chemical sector showed continuous upward movement, with multiple stocks such as Chlor-alkali Chemical and Jintai Titanium Industry hitting the daily limit [1] - Other sectors like semiconductors, photovoltaic equipment, and ride-hailing also showed performance during the trading session [1] Underperforming Stocks - Conversely, AI hardware stocks related to CPO and copper cable high-speed connections underperformed, with Hui Lv Ecology nearing a limit down and stocks like Zhongji Xuchuang and Jianqiao Technology experiencing declines [1]

本报记者 刘钊 1月6日开盘，A股脑机接口概念板块延续强势，多只个股快速封板。截至记者发稿，其中伟思医疗（688580.SH）、三 博脑科（301293）（301293.SZ)、翔宇医疗（688626.SH）、爱朋医疗（300753）（300753.SZ)、美好医疗（301363） （301363.SZ）等多只个股20cm涨停，麦澜德（688273.SH）、诚益通（300430）（300430.SZ）、熵基科技 （301330）（301330.SZ）、博拓生物（688767.SH）等多只个股涨幅居前。 | 물을 | 代码 | 名称 | | 最新 | 涨幅% ↓ | 涨跌 | 成交量 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 688580 | 伟思医疗 | 1 | 69.70 | 20.01 | 11.62 | 8.70万 | | 2 | 301293 | 三博脑科 | 1 | 84.94 | 20.01 | 14.16 | 2.63万 | | 3 | 688626 | 翔宇医疗 | 1 | 87.12 | 20.00 | 14.52 | ...

◼ 建议关注国内在脑机接口领域布局的企业，如翔宇医疗、美好医疗、创新 医疗、三博脑科、爱朋医疗等标的。 评级面临的主要风险 ◼ 脑机接口行业仍然处于发展初期，行业发展仍具备较大的不确定性；相关 公司的产品多处于临床阶段，产品具备临床失败的风险。 医药生物 | 证券研究报告 — 行业点评 2026 年 1 月 6 日 强于大市 脑机接口市场热度较高，密 切关注后续产业进展 事件：近期，美国企业家马斯克在社交媒体上表示，其旗下的脑机接口公司 Neuralink 计划于 2026 年开始对脑机接口设备进行"大规模生产"，并转向 "更加精简和几乎完全自动化的外科手术流程"。在此背景下，国内脑机接 口相关公司获得较高的市场关注度。 支撑评级的要点 投资建议 相关研究报告 《医药行业 2026 年策略报告》20251205 《从"十五五"规划看医药行业未来发展机会》 20251029 《医保局明确集采反内卷，关注医药板块重估 机会》20250729 中银国际证券股份有限公司 具备证券投资咨询业务资格 医药生物 证券分析师：刘恩阳 enyang.liu@bocichina.com 证券投资咨询业务证书编号：S1300523 ...

格隆汇1月6日｜A股开盘，三大指数涨跌不一，沪指高开0.06%报4026.02点，深证成指高开0.01%，创 业板指低开0.45%。盘面上，脑机接口概念延续前日涨势，创新医疗(002173)、倍益康、三博脑科等涨 停；多重利好消息提振，碳酸锂期货今日大涨8%，锂矿股普遍高开。 ...